This Christmas, give your loved ones financial intelligence. Buy two copies of Value.able for the price of one this Christmas. Discount code: XMAS24 BUY NOW
-
Is Capricorn Metals due a re-rate?
Joseph Kim
June 7, 2021
Capricorn Metals is a junior gold company that is entering an exciting time in its development phase. With the company very close to first gold pour and commissioning underway at its 100 per cent owned Karlawinda project in WA, we believe there is significant re-rating potential if the company successfully executes on targeted project metrics over the next 6-12 months. Continue…
by Joseph Kim Posted in Companies, Energy / Resources.
- save this article
- POSTED IN Companies, Energy / Resources.
-
US travel demonstrates vaccination is the path to normal
Roger Montgomery
June 4, 2021
In this week’s video insight Roger discusses why he believes vaccinations are the surest path to reopening. US airlines are reporting steady improvement in bookings, in the last three weeks, booking volumes and prices for July travel have returned to near 2019 levels, with some flights back to 90 per cent capacity. The good news surrounding the benefits of vaccinations keeps coming, will this spur hesitators to get vaccinated?
by Roger Montgomery Posted in Video Insights.
- watch video
- save this article
- POSTED IN Video Insights.
-
Abbott Laboratories building life-changing technologies
Roger Montgomery
June 4, 2021
In March Montgomery Investment Management introduced the Polen Capital Global Growth Fund to Australian investors. The Boca Raton-based manager Polen Capital was established in 1979 and over the past 32 years the flagship US Portfolio has been able to compound earnings growth above 15 per cent annually versus approximately six per cent annually for the S&P 500. Continue…
by Roger Montgomery Posted in Companies, Polen Capital, Stocks We Like.
- save this article
- POSTED IN Companies, Polen Capital, Stocks We Like.
-
Building an export industry for cannabis medicines
Andreas Lundberg
June 3, 2021
The medicinal cannabis industry is gaining significant momentum, however, still remains in the early stages of growth. Zelira Therapeutics recently reported record quarterly cash receipts for the third quarter, up 249 per cent on H1 FY21. Continue…
by Andreas Lundberg Posted in Companies, Health Care.
- save this article
- POSTED IN Companies, Health Care.
-
Discover how to value the best stocks and buy them for less than they’re worth.
NOW FOR JUST $49.95
buy nowSUBSCRIBERS RECEIVE 20% OFF WHEN THEY SIGN UP
“This is a book you simply must read.
The very best investors in the world are “value” investors.” -
MEDIA
Equity Mates – 30 year stocks for Bryce’s 30th
Roger Montgomery
June 2, 2021
Roger joined Alec Renehan and Bryce Leske on Equity Mates to discuss why I think stocks in the medical sector are worth owning for the long term and if I had to buy a stock for 30 years – what would it be?
by Roger Montgomery Posted in Editor's Pick, TV Appearances.
- save this article
- POSTED IN Editor's Pick, TV Appearances.
-
MEDIA
Roger Montgomery shares his insights on the Australian market and advice for new investors
Roger Montgomery
June 2, 2021
Roger joined Grady Wulff from Grafa at the Australian Shareholder’s Association Conference to discuss the outlook for Australian markets over the next 12-months and why buy now pay later stocks don’t meet our quality hurdles.
by Roger Montgomery Posted in Editor's Pick, TV Appearances.
- save this article
- POSTED IN Editor's Pick, TV Appearances.
-
MEDIA
Watchlist Wednesday: Roger’s two stocks and a bank
Roger Montgomery
June 1, 2021
Roger joined Alec Renehan and Bryce Leske on Equity Mates Watchlist Wednesday to discuss Aussie banks. Montgomery purchased CBA and Westpac during the March 2020 COVID-induced sell off. With a stable economic outlook, are the banks able to continue to generate strong credit growth?
by Roger Montgomery Posted in TV Appearances.
- save this article
- POSTED IN TV Appearances.
-
Is it time to tilt to high quality tech names?
Roger Montgomery
June 1, 2021
Over the past year or so, we’ve seen spikes in the valuations of fast growth, momentum stocks. But if inflation rears its head, that could change in a heartbeat. Which is why the next big rotation could see these over-valued – often profitless – firms dumped in favour of long-duration quality tech businesses. Continue…
by Roger Montgomery Posted in Companies, Global markets, Stocks We Like.
- save this article
- POSTED IN Companies, Global markets, Stocks We Like.
